Search Results

You are looking at 81 - 90 of 286 items for :

  • "risk assessment" x
  • Refine by Access: All x
Clear All
Full access

Jeffrey Crawford and George M. Rodgers

resistant bacteria, and do not impact the depth and duration of neutropenia, which is the major risk factor for FN. Risk Assessment Per NCCN Guidelines Before the start of chemotherapy, patients should be evaluated for their risk of FN based on

Full access

were added throughout: ➤ SSR PET tracers include: 68Ga-DOTATATE, 64Cu-DOTATATE, 68Ga-DOTATOC. ➤ See Principles of Genetic Risk Assessment and Counseling (NE-E). • “Somatostatin receptor-based imaging or SSR scintigraphy” was modified to “SSR-PET/CT or

Full access

for the following NCCN Guidelines are available: Acute Lymphoblastic Leukemia, Version 1.2016 Acute Myeloid Leukemia, Version 1.2016 Bladder Cancer, Version 2.2016 Breast Cancer, Version 2.2016 Genetic/Familial High-Risk Assessment: Breast

Full access

Hideki Furuya and Charles J. Rosser

effective cancer risk assessment, early detection, and early diagnosis of bladder cancer, ushering in a new era in bladder cancer diagnosis. Call for Correspondence JNCCN is committed to providing a forum to enhance collaboration between academic

Full access

Robert W. Carlson

Cancer Screening and Diagnosis, and Familial and Genetic High-Risk Assessment: Breast and Ovarian. Similar evolution has occurred in multiple other NCCN Guidelines, and now more than 1000 physicians currently participate as panel members in the NCCN

Full access

Monique A. de Bruin, James M. Ford, and Allison W. Kurian

genetic counseling and testing for BRCA1/2 mutations are recommended according to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast and Ovarian ( Table 1 ; to view the most recent version of

Full access

Michael B. Streiff

issue of JNCCN , Alok Khorana, MD, a leading authority on VTE risk stratification and prevention in patients with cancer, provides an overview of randomized clinical trials of VTE prophylaxis in ambulatory patients with cancer, VTE risk assessment in

Full access

Alicia K. Matthews, Patrick W. Corrigan, and Judith Lee Rutherford

. Attitudes of Hispanics, Black, and Caucasian university students toward mental illness . Hisp J Behav Sci 1981 ; 3 : 241 – 255 . 34 Matthews AK Brandenburg D Cummings S . Incorporating a psychological counselor in a cancer risk

Full access

Wylie Burke and Nancy Press

screening with MRI—what are the data for patients at high risk? N Engl J Med 2004 ; 351 : 497 – 500 . 11. Nelson HD Huffman LH Fu R Harris EL . Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility

Full access

Jeffrey Crawford, David C. Dale, Nicole M. Kuderer, Eva Culakova, Marek S. Poniewierski, Debra Wolff, and Gary H. Lyman

. Talcott JA Siegel RD Finberg R Goldman L . Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule . J Clin Oncol 1992 ; 148 : 2561 – 2568 . 2. Kuderer NM Dale DC Crawford JC